Phase 2 data demonstrate robust immunogenicity, including enhanced response against serotype 3, alongside expanded protection across 25 serotypes; to achieve potential vaccine serotype coverage of 90% ...

The TGA has granted provisional approval to the COVID-19 vaccine, Moderna, for children aged six months to up to six years.

A new Advisory Committee on Immunization Practices (ACIP) workgroup will review childhood and adolescent immunization schedules, a move that infectious disease experts caution could be another step in ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...